Changing metrics when you dislike the results
Kaiser reacts to New York Governer's attempt to re-define what counts as a Covid-19 case.
Assumptions
Open questions of the pandemic, part 1
Kaiser discusses some open questions of the Covid-19 pandemic
Primer on Regression Adjustments 1
Kaiser starts a series of posts about regression adjustments.
Blood clots: is there a there
Kaiser looks at the controversy over blood clots and the Astrazeneca vaccine.
Real-world studies: limits of knowledge
Kaiser focuses attention on a few aspects of the Mayo Clinic real-world effectiveness study.
One-dose Pfizer is not happening and here's why
Kaiser explores what the Pfizer vaccine trial data say about a one-dose treatment.